tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
SGTX is currently covered by 3 analysts with an average price target of $2.49. This is a potential upside of $-19.98 (-88.92%) from yesterday's end of day stock price of $22.47.
Sigilon Therapeutics 's activity chart (see below) currently has 2 price targets and 6 ratings on display. The stock rating distribution of SGTX is 50% BUY and 50% HOLD.
Analysts average stock forecasts to be materialized ratio is 90% with an average time for these price targets to be met of 129.4 days.
Highest price target for SGTX is $23, Lowest price target is $5, average price target is $2.49.
Most recent stock forecast was given by WHITNEY IJEM from CANACCORD on 05-Jul-2023. First documented stock forecast 19-Jul-2021.
Currently out of the existing stock ratings of SGTX, 2 are a BUY (50%), 2 are a HOLD (50%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$30
$7.53 (33.51%)
$6
1 years 4 months 13 days ago
(05-Jul-2023)
1/2 (50%)
$8.45 (39.21%)
127
Hold
$21
$-1.47 (-6.54%)
$7
1 years 4 months 19 days ago
(30-Jun-2023)
3/3 (100%)
$-1.51 (-6.71%)
107
Hold
$14
1 years 4 months 19 days ago
(30-Jun-2023)
1/1 (100%)
$-55.55 (-79.87%)
176
Buy
$12
2 years 10 months 21 days ago
(28-Dec-2021)
3/3 (100%)
$-27 (-69.23%)
111
Buy
$16
$-6.47 (-28.79%)
$48
2 years 11 months 16 days ago
(02-Dec-2021)
2/2 (100%)
$-24.3 (-60.30%)
126
What is SGTX (Sigilon Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on SGTX (Sigilon Therapeutics ) with a proven track record?
Which analyst has the current lower performing score on SGTX (Sigilon Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on SGTX (Sigilon Therapeutics )?
Which analyst is the currently most bullish on SGTX (Sigilon Therapeutics )?
Which analyst is the currently most reserved on SGTX (Sigilon Therapeutics )?
